FTC Case Against Drug Middlemen in Limbo After Trump Firings (1)
President Donald Trump’s move to fire two Democrats on the Federal Trade Commission leaves a question mark over the future of an agency antitrust action alleging pharmacy benefit managers used illegal rebate programs that spiked the price of insulin.
The FTC sued Cigna-owned Express Scripts, CVS-owned Caremark and UnitedHealth-owned Optum Rx in September, arguing that the drug middlemen prefer more expensive insulin products because they ...
Cigna’s Express Scripts and UnitedHealth Group’s OptumRx for a preliminary injunction in the FTC’s in-house case examining their influence over insulin costs. CVS Caremark, Express Scripts ...
The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...
CVS Health's Caremark, Cigna's Express Scripts and UnitedHealth's Optum Rx filed a notice of appeal Friday after a Missouri District Court determined that the FTC's case could move ahead.
the FTC sued Caremark, Express Scripts and Optum Rx over business practices that regulators said were artificially driving up the cost of insulin. The three PBMs, which are owned by CVS, Cigna and ...
Last year, the Federal Trade Commission (FTC) caused consternation ... the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback